Laing Lance G. 4

What Happened

• Lance G. Laing, Chief Science Officer and director of Celcuity (CELC), exercised stock option(s) on 2026-06-02 to acquire 1,000 shares at an exercise price of $9.89 per share, for a cash payment of $9,890. The filing also shows a related derivative conversion/disposition of 1,000 shares at $0, which reflects the settlement/conversion of the derivative instrument tied to the exercise. Footnote indicates the options were fully vested.

Key Details

• Transaction date: 2026-06-02; Filing date: 2026-06-04 (filed timely)
• Acquired: 1,000 shares via exercise at $9.89/share (total $9,890)
• Disposed/converted: 1,000 derivative shares reported at $0 (reflects conversion/settlement of the derivative)
• Footnote: F1 — Fully vested
• Shares owned after transaction: not specified in the provided filing data

Context

• Code M denotes an exercise or conversion of a derivative security (e.g., stock option). The entries indicate an exercise occurred; there is no separate sale reported in this filing, so these look like an option exercise resulting in acquisition/settlement rather than an immediate open‑market sale. Purchases/exercises can signal confidence but do not by themselves reveal the insider’s intent.